Postoperative Care after Transurethral Resection (Transurethral Resection of the Prostate and Transurethral Resection...

Transurethral resection of the prostate (TURP), transurethral resection of bladder tumour, and laser-based alternatives (holmium laser enucleation of the prostate, thulium laser enucleation) account for a substantial share of urological procedures worldwide. Patients are routinely advised to restrict physical activity postoperatively to reduce secondary haemorrhage, yet recommendations vary widely, conflate two distinct clinical phases - immediate mobilization (hours to days) and medium-term convalescence (weeks) - and their evidence base has not been systematically examined.

This PRISMA Extension for Scoping Reviews (PRISMA-ScR) scoping review searched PubMed, Scopus, Embase, and ClinicalTrials.gov (June 1, 2026), with a supplementary search (July 2026) targeting urinary tract infection, orchitis/epididymitis, anticoagulation, and frailty. Of 263 records identified, 31 sources were charted (5 directly relevant, 26 contextual); the supplementary search added 10 contextual sources. No trial compared activity restriction with early mobilization using surgical complication endpoints. No data linked activity level to urinary tract infection or orchitis/epididymitis after transurethral resection. Enhanced recovery after surgery (ERAS) studies incorporating early mobilization showed improved or unchanged recovery without increased complications. All direct evidence addresses the immediate postoperative phase; no study examined medium-term convalescence restrictions as a defined intervention. Frailty, comorbidities, and anticoagulation are clinically relevant risk modifiers but remain unstudied in relation to postoperative activity.

(1) Direct evidence comparing activity restriction with early mobilization after transurethral resection using surgical endpoints is absent. (2) ERAS data support early mobilization within multimodal bundles as feasible and safe. (3) Current recommendations conflate immediate mobilization with medium-term convalescence; future research should address each phase separately. (4) Patient-level factors - frailty, comorbidities, and anticoagulation status - should inform individualized activity recommendations. (5) A focused randomized trial with bleeding, infectious, and return-to-activity endpoints is the research priority.